Dexxon Holdings Inc. Insider Profile
11 Followers
Dexxon Holdings Inc., former Ten Percent Owner at Cynapsus Therapeutics, holds 18.10M shares in Cynapsus Therapeutics (Ticker: CYNA). Most recently, Dexxon Holdings Inc. Bought 4,342,105 shares of Cynapsus Therapeutics on Apr 07, 2015 for an estimated value of $4.12M.
Dexxon Holdings Inc.'s Trading History
| CYNACynapsus Therapeutics | Apr 07, 2015 | ― | Informative Buy | 4.12M | $732.88M | |||||||||||||||||||||||||||||
CYNA
| ||||||||||||||||||||||||||||||||||
You May Also Like
Dexxon Holdings Inc. insider profile FAQ
What is the percentage of profitable transactions made by Dexxon Holdings Inc.?
The percentage of profitable transactions made by Dexxon Holdings Inc. is 50%.
What is the average return per transaction made by Dexxon Holdings Inc.?
The average return per transaction made by Dexxon Holdings Inc. is 20.30%.
What stocks does Dexxon Holdings Inc. hold?
Dexxon Holdings Inc. holds: CYNA stocks.
What was Dexxon Holdings Inc.’s latest transaction?
Dexxon Holdings Inc.’s latest transaction was an Informative Buy of $4.12M.
What was Dexxon Holdings Inc.'s most profitable transaction?
Dexxon Holdings Inc.’s most profitable transaction was an Informative Buy of CYNA stock on April 22, 2014. The return on the trade was 72.70%.
What is Dexxon Holdings Inc.'s role in Cynapsus Therapeutics?
Dexxon Holdings Inc.'s role in Cynapsus Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
